(Q44111090)

29 November 2017

title

The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics (English)

1 reference

29 November 2017

0 references

1 reference

Lee A

1

1 reference

29 November 2017

Patrick P

2

1 reference

29 November 2017

Wishart J

3

1 reference

29 November 2017

Horowitz M

4

1 reference

29 November 2017

Morley JE

5

1 reference

29 November 2017

language of work or name

1 reference

1 September 2002

1 reference

Diabetes, Obesity and Metabolism

29 November 2017

published in

1 reference

29 November 2017

volume

4

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

329-335

1 reference

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Attenuated GLP-1 secretion in obesity: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

The intestinal brush border membrane in diabetes. Studies of sucrase-isomaltase metabolism in rats with streptozotocin diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

The reproducibility of subjective appetite scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Control of food intake. A physiologically complex, motivated behavioral system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00219.X

10.1046/J.1463-1326.2002.00219.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference